Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Asset Utilization Ratio: 2017-2025

Historic Asset Utilization Ratio for Organogenesis Holdings (ORGO) over the last 8 years, with Sep 2025 value amounting to 0.96.

  • Organogenesis Holdings' Asset Utilization Ratio fell 6.34% to 0.96 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.96, marking a year-over-year decrease of 6.34%. This contributed to the annual value of 1.01 for FY2024, which is 5.65% up from last year.
  • Per Organogenesis Holdings' latest filing, its Asset Utilization Ratio stood at 0.96 for Q3 2025, which was up 3.58% from 0.93 recorded in Q2 2025.
  • Over the past 5 years, Organogenesis Holdings' Asset Utilization Ratio peaked at 1.28 during Q2 2021, and registered a low of 0.93 during Q2 2025.
  • Moreover, its 3-year median value for Asset Utilization Ratio was 0.98 (2023), whereas its average is 0.98.
  • In the last 5 years, Organogenesis Holdings' Asset Utilization Ratio slumped by 63.34% in 2021 and then climbed by 8.75% in 2024.
  • Quarterly analysis of 5 years shows Organogenesis Holdings' Asset Utilization Ratio stood at 1.15 in 2021, then declined by 13.41% to 0.99 in 2022, then dropped by 5.61% to 0.94 in 2023, then rose by 8.75% to 1.02 in 2024, then dropped by 6.34% to 0.96 in 2025.
  • Its Asset Utilization Ratio was 0.96 in Q3 2025, compared to 0.93 in Q2 2025 and 0.95 in Q1 2025.